MULTICRITERIA OPTIMIZATION IN INTENSITY-MODULATED RADIATION THERAPY TREATMENT PLANNING FOR LOCALLY ADVANCED CANCER OF THE PANCREATIC HEAD

被引:69
|
作者
Hong, Theodore S. [1 ,2 ]
Craft, David L. [1 ,2 ]
Carlsson, Fredrik [3 ]
Bortfeld, Thomas R. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] RaySearch Labs, Stockholm, Sweden
关键词
Pancreatic cancer; Multicriteria optimization; IMRT;
D O I
10.1016/j.ijrobp.2008.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Intensity-modulated radiation therapy (IMRT) affords the potential to decrease radiation therapy-associated toxicity by creating highly conformal dose distributions. However, the inverse planning process can create a suboptimal plan despite meeting all constraints. Multicriteria optimization (MCO) may reduce the time-consuming iteration loop necessary to develop a satisfactory plan while providing information regarding trade-offs between different treatment planning goals. In this exploratory study, we examine the feasibility and utility of MCO in physician plan selection in patients with locally advanced pancreatic cancer (LAPC). Methods and Materials: The first 10 consecutive patients with LAPC treated with IMRT were evaluated. A database of plans (Pareto surface) was created that met the inverse planning goals. The physician then navigated to an "optimal" plan from the point on the Pareto surface at which kidney dose was minimized. Results: Pareto surfaces were created for all 10 patients. A physician was able to select a plan from the Pareto surface within 10 minutes for all cases. Compared with the original (treated) IMRT plans, the plan selected from the Pareto surface had a lower stomach mean dose in 9 of 10 patients, although often at the expense of higher kidney dose than with the treated plan. Conclusion: The MCO is feasible in patients with LAPC and allows the physician to choose a satisfactory plan quickly. Generally, when given the opportunity, the physician will choose a plan with a lower stomach dose. The MCO enables a physician to provide greater active clinical input into the IMRT planning process. (c) 2008 Elsevier Inc.
引用
收藏
页码:1208 / 1214
页数:7
相关论文
共 50 条
  • [31] Dose-volume constrained optimization in intensity-modulated radiation therapy treatment planning
    Yoshihiro Tanaka
    Ken’ichi Fujimoto
    Tetsuya Yoshinaga
    Journal of Inequalities and Applications, 2015
  • [32] Obstacles and advances in intensity-modulated radiation therapy treatment planning
    Deasy, Joseph O.
    Alaly, James R.
    Zakaryan, Konstantin
    IMRT, IGRT, SBRT: ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 2007, 40 : 42 - 58
  • [33] Dose-volume constrained optimization in intensity-modulated radiation therapy treatment planning
    Tanaka, Yoshihiro
    Fujimoto, Ken'ichi
    Yoshinaga, Tetsuya
    JOURNAL OF INEQUALITIES AND APPLICATIONS, 2015, : 1 - 13
  • [34] Chemoradiotherapy using intensity-modulated radiation therapy (IMRT) for locally advanced cervical esophageal cancer
    Koike, R.
    Nishimura, Y.
    Nakamatsu, K.
    Kanamori, S.
    Ohkubo, M.
    Hiroi, K.
    Shibata, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S310 - S311
  • [35] A Formal Assessment of the Dosimetric Advantages of Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer
    Ackerson, B.
    Boyle, J. M.
    Gu, L.
    Kelsey, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 234 - 234
  • [36] Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer
    Chen, Chien-Chih
    Lin, Jin-Ching
    Jan, Jian-Sheng
    Ho, Shih-Chu
    Wang, Lily
    GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 9 - 13
  • [37] Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial.
    Goodman, Karyn A.
    Pishvaian, Michael J.
    Lopez, Charles D.
    Meredith, Kenneth
    Zervos, Emmanuel E.
    Hatoum, Hassan
    Chung, Ki Y.
    Tsobanoudis, Alex
    Berg, Daniel James
    Ucar, Antonio
    Nazemzadeh, Reza
    Johnson, Thor
    Parikh, Nainesh
    Kouri, Brian
    Laing, Christopher
    Boone, Brian A.
    Qureshi, Imtiaz
    Agah, Ramtin
    Zureikat, Amer H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 713 - 713
  • [38] Initial results of the intensity-modulated radiation therapy for localized and locally advanced prostate cancer (IMRT)
    Kim, Youngjoo
    BJU INTERNATIONAL, 2015, 116 : 5 - 5
  • [39] Intensity-modulated radiation therapy for the treatment of anal cancer
    Lin, Alexander
    Ben-Josef, Edgar
    CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 716 - 719
  • [40] Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol
    Habl, Gregor
    Jensen, Alexandra D.
    Potthoff, Karin
    Uhl, Matthias
    Hof, Holger
    Hajda, Jacek
    Simon, Christian
    Debus, Juergen
    Krempien, Robert
    Muenter, Marc W.
    BMC CANCER, 2010, 10